Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02600897 |
|---|---|
| Brief Title: | A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
| First Submitted : | November 3, 2015 |
| First Submitted that Met QC Criteria : | November 5, 2015 |
| First Posted : | November 9, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 5, 2021 |
| Last Update Posted : | February 8, 2021 |